X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Europe

PersonalMed Partners with Bergen’s Elevate Provider Network to Assist Compounding Pharmacies

Yuvraj_pawp by Yuvraj_pawp
19th July 2017
in Europe, News

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

PersonalMed, LLC, has entered into a collaborative agreement with AmerisourceBergen’s pharmacy services administrative organization (PSAO), Elevate Provider Network, to introduce its pharmacy credentialing program. The program is available to the more than 4,500 independent pharmacies that participate in the Good Neighbor Pharmacy and Elevate Provider Network programs, and is focused on ensuring pharmacists can continue to submit claims for compounded medications to payors that are increasingly adopting credentialing and accreditation requirements.

The relationship will encourage Good Neighbor Pharmacy and Elevate Provider Network members that compound medications to earn the cCert recognition by completing PersonalMed’s compounding certification program and to take advantage of its billing and claims-management services. PersonalMed and AmerisourceBergen will officially launch the credentialing program at ThoughtSpot, Good Neighbor Pharmacy’s annual conference and trade show held July 19 – 21, 2017, at Mandalay Bay in Las Vegas.


Third-party payors – such as healthcare plan sponsors and their pharmacy benefit managers (PBMs) – are increasingly adopting credentialing and accreditation requirements to ensure that the network of pharmacies filling compounded medications meets the highest standards of quality, compliance, accreditation and transparency within their products, pricing and business practices. The goal is to ensure that Elevate members remain in network for compounded medications.


“We are excited to assist those Elevate member pharmacies that want to continue to bill compounded medications to payors,” said Ernie Rapp, president of PersonalMed. “We have seen an increasing number of payors that require credentialing for compound medications. cCert can assist Elevate members with the adherence to best practices and ensure the focus remains on quality and patient needs.”


“Many patients rely on compounded medications as the best form of therapy. and the service is an important niche for many independent pharmacies,” added Chuck Reed, group vice president of pharmacy innovation at AmerisourceBergen. “Introducing this service reaffirms our commitment to supporting the success of independent pharmacies by providing new and innovative solutions that help them accomplish their goals.”


PersonalMed is a leader in providing compounding management solutions and credentialing services; Elevate is one of the largest PSAOs in the country, helping independent pharmacies maximize profitability, improve operational effectiveness and enhance patient care. Elevate Good Neighbor Pharmacy have more than 4,500 members in its care network, and negotiates contracts with over 35 pharmacy benefit managers (PBMs) for more than 7,500 plans.


Credentialing through the joint cCert program is available to members of the Elevate Provider Network and other compounding pharmacies that meet the same participation requirements. For complete details, email contactus@personalmedrx.com or call (844) 901-7832.


About PersonalMed

PersonalMed, LLC, provides services to third-party payors to manage and process claims for compounded medications through (i) its Preferred Provider Network and (ii) its PAGO platform. The Preferred Provider Network is a high-performance network of compounding pharmacies that agree to comply with strict credentialing standards in addition to holding PCAB Accreditation, a service of the Accreditation Commission for Health Care (ACHC). PersonalMed’s credentialing focuses on accreditation, legal compliance, clinical and quality standards, ownership, training, pricing, contract compliance and business practices. PAGO is a cloud-based billing and claims management platform. For more information, visit PersonalMed’s website at www.personalmedrx.com


About AmerisourceBergen

AmerisourceBergen provides pharmaceutical products, value-driving services and business solutions that improve access to care. Tens of thousands of healthcare providers, veterinary practices and livestock producers trust us as their partner in the pharmaceutical supply chain. Global pharmaceutical manufacturers depend on us for services that drive commercial success for their products. Powered by our 19,000 associates, we are united in our responsibility to create healthier futures. AmerisourceBergen is ranked #11 on the Fortune 500, with more than $146 billion in annual revenue. The company is headquartered in Valley Forge, Pa. and has a presence in 50+ countries. Learn more at www.amerisourcebergen.com

 

Contacts
PersonalMed
Del Doherty, Pharm.D., Ph.D., MPH, 844-901-7832
Vice President of Managed Care Services
contactus@personalmedrx.com

Tags: Europe
Previous Post

Thermo Fisher Scientific Introduces Next Generation of Complementary Technologies for Forensic DNA Analysis

Next Post

Lexicon Collaborator Ipsen Receives Positive Chmp Opinion For Xermelo

Related Posts

idiopathic pulmonary fibrosis
Americas

US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

9th October 2025
Tissue Repair Drug
Clinical Trials

FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

7th October 2025
FastTrack Review
Americas

US FDA Launches Fast-Track Review Scheme for Generic Drugs

7th October 2025
AI Based Drug Discovery
Drug Development

Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

1st October 2025
API Manufacturing Facility
Americas

AbbVie Launches New API Manufacturing Facility in Illinois

1st October 2025
U.S. manufacturing
Americas

Amgen to Expand U.S. Manufacturing with $650M Investment

30th September 2025
Next Post

AMO Pharma Enters into Development and License Agreement with Numedicus ltd

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In